Efficacy and Safety Study of F373280

NCT01831856 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

135

Enrollment

INDUSTRY

Sponsor class

Conditions

Atrial Fibrillation

Interventions

DRUG: 1g of F373280
DRUG: Placebo

Sponsor

Pierre Fabre Medicament